Search Results - "Tsareva, N A"

Refine Results
  1. 1

    Combination therapy is a new standard for treatment of pulmonary arterial hypertension by Avdeev, S N, TsarEva, N A, Gaisin, I R

    Published in Terapevtic̆eskii arhiv (19-04-2018)
    “…At present, compelling evidence has been obtained that combined therapy of pulmonary arterial hypertension (PAH) with specific drugs can significantly slow…”
    Get full text
    Journal Article
  2. 2

    A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out? by N A Tsareva, S N Avdeev, G V Neklyudova

    Published in Terapevtic̆eskii arhiv (01-01-2017)
    “…The paper considers a clinical example of current therapy for idiopathic pulmonary arterial hypertension in a female patient with its clinical deterioration…”
    Get full text
    Journal Article
  3. 3

    Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension by Tsareva, N A

    Published in Terapevtic̆eskii arhiv (01-01-2013)
    “…The paper reviews current views of the problem of pulmonary hypertension. It shows the classification of pulmonary hypertension and considers the general…”
    Get full text
    Journal Article
  4. 4

    Clinical guidelines for the diagnosis and treatment of pulmonary hypertension by Chazova, I E, Avdeev, S N, Tsareva, N A, Volkov, A V, Martyniuk, T V, Nakonechnikov, S N

    Published in Terapevtic̆eskii arhiv (01-01-2014)
    “…Pulmonary hypertension (PH) is a group of diseases characterized by progressive increases in pulmonary vascular resistance and pulmonary artery pressure, which…”
    Get full text
    Journal Article
  5. 5

    First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study by Avdeev, S N, tsareva, N A, Nekliudova, G V, Chuchalin, A G

    Published in Terapevtic̆eskii arhiv (01-01-2013)
    “…To evaluate the efficiency and safety of long-term (12-month) treatment with the endothelin receptor antagonist bosentan (tracleer (Actelion, Switzerland)) in…”
    Get full text
    Journal Article
  6. 6

    Risk stratification methods and their significance in pulmonary arterial hypertension by Avdeev, S N, Tsareva, N A

    Published in Terapevtic̆eskii arhiv (15-09-2019)
    “…Despite significant advances in therapy, pulmonary arterial hypertension (PAH) remains a progressive disease with a poor prognosis. Immediately after…”
    Get full text
    Journal Article
  7. 7

    Triple combination therapy with macitentan, riociguat, and selexipag in a patient with idiopathic pulmonary arterial hypertension (functional class III) by Proshkina, A A, Tsareva, N A, Nekludova, G V, Avdeev, S N

    Published in Kardiologiia (30-10-2021)
    “…The article presents a clinical case of successful triple combination therapy in a female patient with functional class III idiopathic pulmonary arterial…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Exacerbation of idiopathic pulmonary fibrosis by Avdeev, S. N., Gaynitdinova, V. V., Merzhoeva, Z. M., Neklyudova, G. V., Tsareva, N. A., Nuralieva, G. S.

    Published in Terapevtic̆eskii arhiv (27-03-2020)
    “…Idiopathic pulmonary fibrosis (IPF) is usually characterized by a chronic and slowly progressive course. According to several studies, a small number of…”
    Get full text
    Journal Article
  10. 10

    Riociguat is a novel medication for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension by N. A. Tsareva, S. N. Avdeev

    Published in Medicinskij sovet (01-12-2016)
    “…Pulmonary hypertension (PH) is a progressive and potentially dangerous, life-threatening disease. A variety of different diseases can be associated with a…”
    Get full text
    Journal Article
  11. 11

    INFLUENCE OF PULMONARY HYPERTENSION ON CLINICAL COURSE AND PROGNOSIS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE by Avdeev, S. N., Gajnitdinova, V. V., Tsareva, N. A., Merzhoeva, Z. М.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (11-07-2018)
    “…Aim. Evaluation of clinical specifics, predictors of repeat hospitalizations and mortality in chronic obstructive pulmonary disease (COPD) patients according…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Rapid evolution of translational control mechanisms in RNA genomes by Klovins, J., Tsareva, N.A., de Smit, M.H., Berzins, V., van Duin, J.

    Published in Journal of molecular biology (31-01-1997)
    “…We have introduced 13 base substitutions into the coat protein gene of RNA bacteriophage MS2. The mutations, which are clustered ahead of the overlapping lysis…”
    Get full text
    Journal Article
  14. 14

    Secondary pulmonary hypertension: some aspects of pathogenesis by G V Neklyudova, S N Avdeev, N A Tsareva, A L Chernyaev, M V Samsonova, Zh K Naumenko, L M Mikhale

    Published in Terapevtic̆eskii arhiv (01-01-2012)
    “…To study morphofunctional condition of pulmonary vessels in chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), to specify…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Obesity – hypoventilation syndrome by Nuralieva, G. S., Bodunkov, M. V., Bikbauv, K. I., Samoilov, E. A., Tsareva, N. A., Trushenko, N. V., Avdeev, S. N.

    Published in Medicinskij sovet (13-04-2023)
    “…Obesity is a rapidly growing social problem that affects more than 650 million people worldwide. It has been proven that obesity is associated with diabetes…”
    Get full text
    Journal Article
  18. 18

    Cyclosporine A therapy in patients with COVID-19 and failure of immunosuppression therapy: a retrospective cohort propensity-score matched analysis by Merzhoeva, Z. M., Yaroshetskiy, A. I., Savko, S. A., Krasnoshchekova, A. P., Mandel, Irina A., Tsareva, N. A., Trushenko, N. V., Nuralieva, G. S., Avdeev, S. N.

    Published in Vestnik intensivnoĭ terapii (30-10-2023)
    “…INTRODUCTION: Therapy of COVID-19 patients with progressive lung damage after the use of glucocorticosteroids (GCS) and interleukin-6 inhibitors (IIL-6) has…”
    Get full text
    Journal Article
  19. 19

    Long-term oxygen therapy for chronic obstructive pulmonary disease: results from an observational cohort study by Nuralieva, G. S., Shmidt, A. E., Nekludova, G. V., Gaynitdinova, V. V., Tsareva, N. A., Chikina, S. Yu, Merzhoeva, Z. M., Trushenko, N. V., Karchevskaya, N. A., Avdeev, I. S., Tkachenko, V. V., Krokhin, K. A., Avdeev, S. N.

    Published in Medicinskij sovet (19-08-2023)
    “…Introduction. Chronic obstructive pulmonary disease (COPD) is a disease characterized by the persistent restriction of airflow and is a consequence of chronic…”
    Get full text
    Journal Article
  20. 20

    Applying vibroacoustic therapy in the treatment of patients with COVID-associated pneumonia by Nuralieva, G. S., Shmidt, A. S., Nekludova, G. V., Gaynitdinova, V. V., Tsareva, N. A., Merzhoeva, Z. M., Chikina, S. Yu, Trushenko, N. V., Berikkhanov, Z. G., Suvorova, O. A., Kurkieva, F. T., Avdeev, I. S., Bolotskaia, A. A., Avdeev, S. N.

    Published in Medicinskij sovet (09-05-2024)
    “…Introduction. Pneumonia is a group of acute infectious (mainly bacterial) diseases of various etiology, pathogenesis, and morphological characteristics…”
    Get full text
    Journal Article